Excellence in everything we do.
Dresner Partners | Recent News
  • Drenser Partners
  • Drenser Partners
  • Drenser Partners
  • Drenser Partners
  • Drenser Partners
<< Back to News List            Dresner Partners Acted as Financial Advisor to... >>

Dresner Partners Collaborated with Arcano on the Recent Sale of IGENOMIX
Monday, September 12, 2016
DRESNER PARTNERS COLLABORATED WITH ARCANO ON
THE RECENT SALE OF IGENOMIX


CHICAGO – September 12, 2016 – Dresner Partners, a leading FINRA-registered middle-market investment bank and IMAP member firm, announced today that it collaborated as an advisor to Arcano Group of Madrid (Spain) on the recent sale of IGENOMIX, a leading provider of genetic testing services for reproductive health patients and clinics, to Charme Capital Partners, Amadeus Capital Partners, Aleph Capital, and Graham Snudden.  Terms of the transaction were not disclosed. 

“It was a pleasure being involved in a healthcare transaction of this caliber,” said Mitchell Stern, Managing Director and Head of Healthcare at Dresner Partners.  “IGENOMIX is an industry leader in genetic testing laboratory services throughout Europe and in the United States.”

“Cross border transactions are always challenging, but Dresner Partners in collaboration with Arcano Group worked seamlessly together as a united team, in both Madrid and New York,” said Robert Friedman, Managing Director and Senior Advisor in Dresner's Healthcare Group.

Steven M. Dresner, President of Dresner Partners added, “We are pleased that our collaborative effort with Arcano Group resulted in a successful sale for IGENOMIX.  This is a true cross-border transaction as the Company has a global presence with eight advanced specialist laboratories throughout the world including Spain (Valencia), U.S. (New York, Miami, and Los Angeles), India (New Delhi), Brazil (Sao Paulo), U.A.E. (Dubai) and Mexico (Mexico City).”

Headquartered in Valencia, Spain, IGENOMIX was created in 2011 when it was spun-out from Instituto Valenciano de Infertilidad (IVI).  Today it is one of the world’s leading providers of advanced services in reproductive genetics, operating from eight laboratories worldwide.  More information on IGENOMIX can be found at www.igenomix.com. 

About Dresner Partners
Dresner Partners is a FINRA-registered, middle-market investment bank headquartered in Chicago, with offices in New York City, Irvine and Palo Alto, Calif., and Richmond, Va.  For nearly 25 years, Dresner Partners has provided financial advisory services to middle market companies throughout the world, including institutional private placements of debt and equity, merger and acquisitions advisory, financial restructuring & corporate turnarounds, valuations and strategic consulting services.  Dresner Partners is a member of IMAP, an exclusive
global organization of leading merger and acquisition advisory firms.  An affiliated company, Dresner Corporate Services, is a strategic communications firm specializing in public and investor relations.  More information is available at www.dresnerpartners.com or http://www.imap.com/city?city=Chicago.  You can also follow Dresner Partners on Twitter at www.twitter.com/DresnerPartners.     

About Arcano Group
Arcano Corporate, headquartered in Madrid, Spain, is a leading European investment bank advisor in local and international mid-market transactions, including mergers and acquisitions, restructurings and IPOs.  Its multidisciplinary team is comprised of 53 professionals, most of them with an international track record in investment banking and with more than 50 M&A deals closed in the last 7 years.  More information on Arcano Corporate can be found at https://en.arcanogroup.com/banca-inversion/quienes-somos/. 

# # #

For Investment Banking Inquiries
Mitchell Stern, Managing Director, Head of Healthcare, (212) 203-8449, mstern@dresnerco.com
Robert Friedman, Jr., Managing Director, Healthcare (212) 203-8449, rfriedman@dresnerco.com